Losartan Potassium and Hydrochlorothiazide Tablets 50 mg/12.5mg Recall: Foreign Material
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc.…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Losartan Potassium recalled?
Presence of foreign substance: plastic-like substance.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
Which lot codes, UPCs or models are affected?
Lot #: BLK2304A, Exp. 07/31/2025
- Agency record number
- D-0498-2024
- Product
- Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc.…
- Recalling firm
- MACLEODS PHARMA USA, INC
- Quantity
- 1,048 bottles
- Distribution
- USA Nationwide
- Recall started
- May 7, 2024
- Report date
- May 22, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)